The question reasonably arises as whether or not shares of Supreme Cannabis Company Inc (OTCMKTS:SPRWF) could be poised to return to its former role as an upside leader in the cannabis space. The stock’s close to the action last week following its strong hold above an upward sloped 200-day simple moving average serves as a strong point here. To further flesh out the story, the company just announced the launch of Cambium Plant Sciences, located in Goderich, Ontario.
According to the release, “Cambium, a wholly-owned subsidiary of Supreme Cannabis, aims to lead the agricultural revolution of cannabis genetics, redefining consumer experiences and cultivation economics across the global cannabis industry. With the systematic application of research, technology and science, Cambium will focus on developing the next generation of premium cannabis genetics for recreational, medical and wellness applications. Cambium’s innovative mission is to supply agriculturally-focused, disease resistant, premium seed stock to the rapidly growing global cannabis market.”
Supreme Cannabis Company Inc (OTCMKTS:SPRWF) trumpets itself as a Canadian publicly traded company committed to providing premium brands and products that proudly reflect its consumers, people, and uniquely innovative culture. The Company’s portfolio includes its wholly-owned subsidiary and flagship brand 7ACRES.
7ACRES is a federally licensed producer of medical cannabis operating inside a 342,000-square-foot facility in Kincardine, Ontario. 7ACRES is dedicated to providing consumers with a premium-quality product that recognizes its customers are informed, discerning and value a brand and culture that aligns with their principles. 7ACRES brand success has been reflected in provincial supply agreements, where 7ACRES’ product is consistently listed in the highest brand category available to recreational consumers.
The Company’s growing portfolio also includes an equity investment and long-term global distribution partnership with Lesotho-based Medigrow for the exporting of medical-grade cannabis oil.
According to company materials, “the company focuses on the production and sale of medical marijuana in Canada. The company was formerly known as Supreme Resources Ltd. and changed its name to Supreme Pharmaceuticals Inc. in February 2014. Supreme Pharmaceuticals Inc. was incorporated in 1979 and is headquartered in Vancouver, Canada. The Supreme Cannabis Company has consistently set the standard for innovation in the sector, including the design of growing facilities and development of operational excellence metrics. We are confident that together with our flagship brand, proprietary technology and products, truly unique culture, and industry-leading team, we will deliver consistent long-term value creation to our shareholders.”
Find out when $SPRWF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, SPRWF just announced the launch of Cambium Plant Sciences, located in Goderich, Ontario.
Traders will note 6% during the past week in terms of shareholder gains in the company. In addition, the stock has witnessed a pop in interest, as transaction volume levels have recently pushed 12% beyond its prior sustained average level.
“Our proprietary genetics selection methodology and ability to cultivate high-end cannabis at scale at 7ACRES has created strong industry demand for our proprietary genetics and cultivation techniques. It was as a result of the demand that we saw a global opportunity to create a company whose sole focus is innovating plant genetics and cultivation IP for the global cannabis market. We believe genetics are the foundation of proprietary cannabis products in the long term,” said Navdeep Dhaliwal, CEO of Supreme Cannabis. “Cambium will develop cultivars that benefit our in-house brands, as well as our domestic and global cultivation and manufacturing partners. Initially, Cambium is expected to benefit from 7ACRES’ established genetics, existing infrastructure and the unparalleled plant knowledge of its team.”
Now commanding a market cap of $449.74M, SPRWF has a significant war chest ($92M) of cash on the books, which is balanced by about $25.9M in total current liabilities. One should also note that debt has been growing over recent quarters. SPRWF is pulling in trailing 12-month revenues of $18.5M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 359.3%. You can bet we will update this one again as new information comes into view. Sign-up for continuing coverage on shares of $SPRWF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $SPRWF, either long or short, and we have not been compensated for this article.